If membrane structures e.g. beta-catenin-E-cadherin can stabilize lipid rafts [45] to facilitate the assembly of active drug transporter complexes, then cisplatin can increase drug efflux and lower intracellular anti-cancer drug levels in such a way that gene transcription is not even involved in the process. Here, CTNNB1 is linked to cancer.